Logo image of CURI

CURIOSITYSTREAM INC (CURI) Stock Fundamental Analysis

USA - NASDAQ:CURI - US23130Q1076 - Common Stock

4.56 USD
-0.1 (-2.15%)
Last: 11/14/2025, 8:00:00 PM
4.64 USD
+0.08 (+1.75%)
After Hours: 11/14/2025, 8:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CURI. CURI was compared to 79 industry peers in the Entertainment industry. While CURI seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, CURI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CURI has reported negative net income.
CURI had a positive operating cash flow in the past year.
CURI had negative earnings in each of the past 5 years.
In the past 5 years CURI reported 4 times negative operating cash flow.
CURI Yearly Net Income VS EBIT VS OCF VS FCFCURI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

CURI's Return On Assets of -6.07% is on the low side compared to the rest of the industry. CURI is outperformed by 63.29% of its industry peers.
CURI's Return On Equity of -9.57% is in line compared to the rest of the industry. CURI outperforms 48.10% of its industry peers.
Industry RankSector Rank
ROA -6.07%
ROE -9.57%
ROIC N/A
ROA(3y)-32.15%
ROA(5y)-36.84%
ROE(3y)-44.33%
ROE(5y)-58.97%
ROIC(3y)N/A
ROIC(5y)N/A
CURI Yearly ROA, ROE, ROICCURI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

CURI has a better Gross Margin (53.07%) than 62.03% of its industry peers.
In the last couple of years the Gross Margin of CURI has remained more or less at the same level.
CURI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
CURI Yearly Profit, Operating, Gross MarginsCURI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

CURI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CURI has been increased compared to 1 year ago.
Compared to 5 years ago, CURI has more shares outstanding
CURI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CURI Yearly Shares OutstandingCURI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CURI Yearly Total Debt VS Total AssetsCURI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 0.58, we must say that CURI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CURI (0.58) is comparable to the rest of the industry.
CURI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.58
ROIC/WACCN/A
WACC8.78%
CURI Yearly LT Debt VS Equity VS FCFCURI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.66 indicates that CURI should not have too much problems paying its short term obligations.
CURI has a Current ratio of 1.66. This is in the better half of the industry: CURI outperforms 70.89% of its industry peers.
CURI has a Quick Ratio of 1.66. This is a normal value and indicates that CURI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.66, CURI is in the better half of the industry, outperforming 73.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.66
CURI Yearly Current Assets VS Current LiabilitesCURI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 67.86% over the past year.
The Revenue for CURI has decreased by -10.12% in the past year. This is quite bad
The Revenue for CURI have been decreasing by -10.47% on average. This is quite bad
EPS 1Y (TTM)67.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-10.12%
Revenue growth 3Y-10.47%
Revenue growth 5YN/A
Sales Q2Q%45.67%

3.2 Future

The Earnings Per Share is expected to grow by 50.40% on average over the next years. This is a very strong growth
Based on estimates for the next years, CURI will show a quite strong growth in Revenue. The Revenue will grow by 13.02% on average per year.
EPS Next Y90.44%
EPS Next 2Y45.49%
EPS Next 3Y32.36%
EPS Next 5Y50.4%
Revenue Next Year36.26%
Revenue Next 2Y22.11%
Revenue Next 3Y20.16%
Revenue Next 5Y13.02%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CURI Yearly Revenue VS EstimatesCURI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
CURI Yearly EPS VS EstimatesCURI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CURI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CURI is valuated quite expensively with a Price/Forward Earnings ratio of 162.57.
CURI's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 34.59. CURI is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 162.57
CURI Price Earnings VS Forward Price EarningsCURI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 150

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CURI indicates a somewhat cheap valuation: CURI is cheaper than 60.76% of the companies listed in the same industry.
CURI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CURI is cheaper than 78.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.6
EV/EBITDA 21.08
CURI Per share dataCURI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CURI's earnings are expected to grow with 32.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.49%
EPS Next 3Y32.36%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.87%, CURI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 41.63, CURI pays a better dividend. On top of this CURI pays more dividend than 93.67% of the companies listed in the same industry.
CURI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 6.87%

5.2 History

CURI is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CURI Yearly Dividends per shareCURI Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

The earnings of CURI are negative and hence is the payout ratio. CURI will probably not be able to sustain this dividend level.
DP-322.61%
EPS Next 2Y45.49%
EPS Next 3Y32.36%
CURI Yearly Income VS Free CF VS DividendCURI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

More info and screens

CURIOSITYSTREAM INC

NASDAQ:CURI (11/14/2025, 8:00:00 PM)

After market: 4.64 +0.08 (+1.75%)

4.56

-0.1 (-2.15%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-09 2026-03-09/amc
Inst Owners20.99%
Inst Owner Change56.74%
Ins Owners7.56%
Ins Owner Change1.58%
Market Cap264.16M
Revenue(TTM)51.13M
Net Income(TTM)-4.77M
Analysts86
Price Target6.41 (40.57%)
Short Float %5.54%
Short Ratio4.11
Dividend
Industry RankSector Rank
Dividend Yield 6.87%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-322.61%
Div Incr Years1
Div Non Decr Years1
Ex-Date09-05 2025-09-05 (0.08)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)6.66%
Min Revenue beat(2)-0.09%
Max Revenue beat(2)13.4%
Revenue beat(4)2
Avg Revenue beat(4)1.87%
Min Revenue beat(4)-9.67%
Max Revenue beat(4)13.4%
Revenue beat(8)3
Avg Revenue beat(8)0.63%
Revenue beat(12)6
Avg Revenue beat(12)-2.69%
Revenue beat(16)7
Avg Revenue beat(16)-2.52%
PT rev (1m)0%
PT rev (3m)11.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.5%
EPS NY rev (1m)-50%
EPS NY rev (3m)15.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.76%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 162.57
P/S 4.34
P/FCF 26.6
P/OCF 26.4
P/B 5.3
P/tB 12.42
EV/EBITDA 21.08
EPS(TTM)-0.09
EYN/A
EPS(NY)0.03
Fwd EY0.62%
FCF(TTM)0.17
FCFY3.76%
OCF(TTM)0.17
OCFY3.79%
SpS1.05
BVpS0.86
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.07%
ROE -9.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.07%
FCFM 16.32%
ROA(3y)-32.15%
ROA(5y)-36.84%
ROE(3y)-44.33%
ROE(5y)-58.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.26%
GM growth 5YN/A
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 0.47%
Cap/Sales 0.13%
Interest Coverage N/A
Cash Conversion 98.19%
Profit Quality N/A
Current Ratio 1.66
Quick Ratio 1.66
Altman-Z 0.58
F-Score7
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)0.12%
Cap/Depr(5y)1.04%
Cap/Sales(3y)0.06%
Cap/Sales(5y)0.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y90.44%
EPS Next 2Y45.49%
EPS Next 3Y32.36%
EPS Next 5Y50.4%
Revenue 1Y (TTM)-10.12%
Revenue growth 3Y-10.47%
Revenue growth 5YN/A
Sales Q2Q%45.67%
Revenue Next Year36.26%
Revenue Next 2Y22.11%
Revenue Next 3Y20.16%
Revenue Next 5Y13.02%
EBIT growth 1Y57.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.64%
EBIT Next 3Y49.23%
EBIT Next 5Y26.01%
FCF growth 1Y131.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y131.29%
OCF growth 3YN/A
OCF growth 5YN/A

CURIOSITYSTREAM INC / CURI FAQ

What is the fundamental rating for CURI stock?

ChartMill assigns a fundamental rating of 3 / 10 to CURI.


What is the valuation status of CURIOSITYSTREAM INC (CURI) stock?

ChartMill assigns a valuation rating of 3 / 10 to CURIOSITYSTREAM INC (CURI). This can be considered as Overvalued.


Can you provide the profitability details for CURIOSITYSTREAM INC?

CURIOSITYSTREAM INC (CURI) has a profitability rating of 1 / 10.


Can you provide the financial health for CURI stock?

The financial health rating of CURIOSITYSTREAM INC (CURI) is 5 / 10.


Can you provide the expected EPS growth for CURI stock?

The Earnings per Share (EPS) of CURIOSITYSTREAM INC (CURI) is expected to grow by 90.44% in the next year.